Follow The Filings

G Genpact

Genpact earnings company data as of 7:50 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.93 — —
Rev — — —

Insider trades

Open-market buys and sales by G's executives, directors and 10% owners in the last 12 months, from their Form 4s

All G insider trades
  • None no insider bought on the open market
  • $6.7M sold by 6 insiders outside a trading plan
  • $1.5M sold by 2 insiders under 10b5-1 plans
  1. Balkrishan Kalra CEO
    Sale
    $368K 10,000 shares at $36.79 2% of stake
    Traded Sep 14 Filed Sep 16
  2. Anil Nanduru Senior Vice President
    Sale
    $229K 6,191 shares at $37.03 8.1% of stake
    Traded Aug 19 Filed Aug 20
  3. Sameer Dewan Senior Vice President
    Sale
    $511K 14,972 shares at $34.10 26% of stake
    Traded Aug 14 Filed Aug 18
  4. Michael Hal Weiner CFO
    Sale
    $201K 5,900 shares at $34.04 3.2% of stake
    Traded Aug 13 Filed Aug 14
  5. Anil Nanduru Senior Vice President
    Sale
    $988K 29,095 shares at $33.94 28% of stake
    Traded Aug 11–12 Filed Aug 13
  6. Balkrishan Kalra CEO
    Sale
    $114K 2,800 shares at $40.77 0.5% of stake
    Traded Mar 4 Filed Mar 5
  7. Sameer Dewan Senior Vice President
    Planned sale
    $704K 15,088 shares at $46.65 29% of stake
    Traded Jan 13 Filed Jan 13
  8. Riju Vashisht Senior Vice President
    Planned sale
    $747K 16,016 shares at $46.65 14% of stake
    Traded Jan 13 Filed Jan 13
  9. Michael Hal Weiner CFO
    Sale
    $599K 13,365 shares at $44.84 8.3% of stake
    Traded Nov 14, 2025 Filed Nov 17, 2025
  10. Sameer Dewan Senior Vice President
    Sale
    $1.2M 26,531 shares at $44.70 30% of stake
    Traded Nov 11, 2025 Filed Nov 13, 2025
  11. Tamara Franklin Director
    Sale
    $126K 2,750 shares at $45.65 11% of stake
    Traded Nov 12, 2025 Filed Nov 13, 2025
  12. Heather White SVP & Chief Legal Officer
    Sale
    $2.3M 51,093 shares at $45.71 50% of stake
    Traded Nov 11–13 Filed Nov 13, 2025

Also filed in the last 12 months, not counted as buying or selling: 26 stock grants, 12 share withholdings for taxes, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
424B3
8-K/A 5.02,9.01
8-K 5.02,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G —
8-K 5.07
SCHEDULE 13G/A —
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.